Epigenome-Wide Association Study of Incident Type 2 Diabetes in a British Population: EPIC-Norfolk Study
Alexia Cardona(University of Cambridge), Ken K. Ong(University of Cambridge), Stephan Beck(London Cancer), John C. Chambers(Nanyang Technological University), Dirk S. Paul(AstraZeneca (United Kingdom)), John R. B. Perry(University of Cambridge), Marie Loh(Agency for Science, Technology and Research), James B. Meigs(Broad Institute), Richard David Leslie(Queen Mary University of London), Kay‐Tee Khaw(University of Cambridge), Luca A. Lotta(University of Cambridge), Jaspal S. Kooner(Imperial College Healthcare NHS Trust), Charlotte Ling(Malmö University), Josée Dupuis(Boston University), Marie‐France Hivert(Massachusetts General Hospital), Claudia Langenberg(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Jussi Pihlajamäki(University of Eastern Finland), Michael Mendelson(Boston Children's Hospital), Felix R. Day(University of Cambridge), Nita G. Forouhi(University of Cambridge), Allan Vaag(Steno Diabetes Centers), Daniel Levy(National Heart Lung and Blood Institute), Chunyu Liu(Southwest Medical University), Nicholas J. Wareham(University of Cambridge), Nicola D. Kerrison(University of Cambridge), Audrey Y. Chu(University of Helsinki), Benjamin Lehne(Centre for Human Genetics), Alexander Perfilyev(Scania (Sweden)), Isobel D. Stewart(University of Cambridge), Robert A. Scott(Age UK)
Cited by 155
Related Papers
Initial sequencing and analysis of the human genome
|Nature|2001|24.6k
Prediction of Coronary Heart Disease Using Risk Factor Categories
|Circulation|1998|9.6k
Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study
|New England Journal of Medicine|1990|5.7k
Impact of Atrial Fibrillation on the Risk of Death
|Circulation|1998|4.6k